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Objective: Fenestrated stent grafting has become increasingly popular as a means to manage complex aortic pathology,
including juxta- and pararenal aneurysms. The design of a recently developed custom-made fenestrated stent graft, in
theory, confers advantages when managing anatomically challenging aortic morphology. This study evaluated its feasi-
bility in anatomically challenging scenarios.
Methods: Over a 12-month period, 20 patients received fenestrated stent grafts. Among those, 13 patients with juxtarenal
or type IV thoracoabdominal aortic aneurysms underwent endovascular repair with the novel fenestrated stent graft at
a single UK institution. Data on aneurysm morphology and immediate and short-term results were collected
prospectively.
Results: The mean aneurysmal sac size was 7.3 cm (range, 5.5-10.0 cm). The mean infrarenal neck length was 4.4 mm
(range, 0-9 mm), and in three cases was lined by a pre-existing infrarenal stent graft. Nine cases had an infrarenal neck
angulation of 60

or more in either the anteroposterior or coronal planes. Five cases had $50% thrombus at the proximal
landing zone. A total of 35 target vessels were cannulated, of which six right renal and four left renal arteries were
angulated $120

. Two-thirds of cannulated celiac trunks were angulated $120

, and one cannulated superior mesenteric
artery was angulated $ 140

. Seven of the cannulated targets were stenosed more than 60%. One patient had two right
renal arteries arising 3 mm from each other. Four right and four left common iliac arteries were angulated $90

in
relation to the infrarenal aorta. Technical success was 100%. Median time from date of procedure to most recent follow-
up with computed tomography scanning was 33 weeks. There was no type I or III endoleak. One type II endoleak was
observed at the time of most recent computed tomography scanning and treated expectantly. There was a single incident
of left renal artery occlusion. One patient required repair of a brachial artery, fasciotomies, and temporary haemoﬁl-
tration. One patient died from ischemic heart disease 77 weeks after the procedure.
Conclusions: The use of the novel fenestrated stent graft system in patients with hostile aortic aneurysmal morphology is
feasible with acceptable short-term outcomes. (J Vasc Surg 2014;59:615-22.)Since the introduction of endovascular aneurysm exclu-
sion by Parodi et al, stent graft design has undergone
constant evolution, largely driven by recognition of graft-
associated complications including endoleaks, stent migra-
tion, infection, and iliac limb kinking and occlusion.1
Despite improvements in graft and fabric technology and
demonstrated improvements in morbidity and mortality,
hostile anatomic factors including short (<15 mm) and
angulated (>60

) proximal aneurysmal neck, inclusion of
visceral branches, tortuous and narrow access vesselsthe Imperial Vascular Unit,a and Department of Interventional Radi-
ogy,b Imperial College Healthcare National Health Service Trust.
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late data from endovascular aneurysm repair (EVAR) trials
have shown that using infrarenal abdominal aortic aneu-
rysm (IRAAA) EVAR stents outside instructions-for-use
may result in signiﬁcantly more late complications and
graft-related adverse events.3-5 In order to overcome these
anatomical restrictions and decrease long-term complica-
tion rates, fenestrated stent grafting was developed; allow-
ing use of the visceral segment as a landing zone if the
aneurysmal neck is deemed too short, or actual exclusion
of an aneurysm that involves visceral target vessels. Subse-
quent studies have demonstrated fenestrated endovascular
aortic repair (FEVAR) as a reliable means to treat aneu-
rysms with complex morphology involving visceral aortic
segments, with lower overall mortality as compared to
open repair and with high short- and mid-term target vessel
patency rates.6-9
Nevertheless, the suitability for this technology is
hampered by planning and technical difﬁculties secondary
to hostile anatomy. In a study of 70 patients with complex
aortic aneurysms, only 60% of patients were deemed suit-
able for mainstream fenestration technology.10 New
designs of FEVAR devices have been developed to address
the current limitations.11615
Table I. Patient demographics
Patient No. Sex Age, years Comorbidities ASA
1 F 87 Hypertension, osteoarthritis III
2 M 69 Hypertension, smoker, hypercholesterolemia, COPD, pancreatitis, peptic ulcer disease III
3 M 83 Hypertension, smoker, colorectal Ca III
4 M 69 Type II diabetes, hypertension, ischemic heart disease, obesity III
5 F 73 Type II diabetes, hypertension, smoker, ischemic heart disease, hypercholesterolemia, COPD III
6 F 72 Hypertension, smoker, breast Ca, uterine Ca, single functioning right kidney III
7 M 87 Hypertension, smoker, diabetes III
8 M 75 Hypertension, hypercholesterolaemia IV
9 F 77 Smoker, hypertension, congestive cardiac failure, COPD III
10 M 84 Smoker, hypertension, cerebro-vascular accident III
11 F 86 Paroxysmal AF, TIA, hypertension, ischemic heart disease III
12 M 72 Smoker, hypertension, AF, ischemic heart disease III
13 M 68 Smoker, hypertension, AF III
AF, Atrial ﬁbrillation; ASA, American Society of Anesthesiologists; Ca, cancer; COPD, chronic obstructive pulmonary disease; TIA, transient ischemic attack.
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ence with the custom-made Anaconda fenestrated stent
graft system (Vascutek, Inchinnan, United Kingdom) in
a series of patients with complex anatomy best suited to
this stent graft system. In particular, emphasis is placed
on the anatomical challenges presented by each case in
this series, encompassing short and angulated aneurysmal
necks, re-do endovascular procedures with existing stent
grafts in place, excessively tortuous iliacs, and stenosed or
aberrant target vessel anatomy in some cases. The authors
have no relationship with Vascutek, and the company did
not sponsor this article.
METHODS
Patient selection. Between August 2011 and August
2012, 20 patients received fenestrated stent grafts; 13 of
them were included in this study. Over the same time
period, 18 patients underwent open repair for juxtarenal
or thoracoabdominal aortic aneurysms. Patients were
selected on the basis of having two or more of the chal-
lenging anatomical features described below, which, in
a number of cases, required the use of a graft outside the
instructions-for-use for existing fenestrated devices. The
design of the fenestrated Anaconda stent graft system was
determined to be appropriate in these cases, given its
repositionable and unsupported body, which afforded
ﬂexibility when aligning fenestrations in cases of severe
proximal angulation or challenging access vessels. The
ability to cannulate fenestrations via a proximal brachial
approach further facilitated cannulation of caudally oriented
target vessels. Data were prospectively collected on patient
demographics and comorbidities (Table I), and abdominal
aortic aneurysm and target vessel anatomy. All computed
tomographies (CTs) were examined by a single radiologist
and angulation measured according to the scheme given in
Fig 1. Stent graft, procedural, and follow-up data including
CT examinations were collated. Our normal threshold for
treating standard infrarenal aneurysms is 5.5 cm. Indica-
tions for fenestrated stenting in complex aneurysms were
aneurysm size above or equal to 6 cm or growth exceeding1 cm per year, together with unsuitable proximal necks
(<1 cm, conical) or an aneurysm that involved the visceral
segment. The speciﬁc indications for treatment of patients
with complex aneurysms below 6 cm were: Female gender,
rapid growth, and patient anxiety.
All patients underwent preoperative high-resolution
computed tomographic angiography (CTA) and selective
preoperative cardiac and pulmonary assessment including
stress-echocardiography, pulmonary function testing, and
MAG-III scanning. Three-dimensional and multiplanar
workstation (Phillips Healthcare, Andover, Mass) recon-
structions were performed in order to assess aneurysm
morphology and plan graft dimensions. Following
multidisciplinary team discussion, devices were customized
to include all those vessels deemed essential for target
organ function. Unfavorable anatomy in this series was
deﬁned as cases having two or more of the following char-
acteristics: Infrarenal neck angulation $60

, down-stream
angulation of renal arteries and celiac trunk $120

, angu-
lation of superior mesenteric artery (SMA) $140

and
common iliac artery angulation $90

, ostial stenosis
>60%, multiple targets in close proximity #3 mm (eg,
two right renals), and pre-existing infrarenal aortic stents
with suprarenal ﬁxation.10
Anaconda abdominal aortic aneurysm stent graft
system. The custom fenestrated Anaconda system has
previously been described in detail.2 The Anaconda
system consists of three separate components; the aortic
endograft and two separate iliac legs. The proximal end of
the main body of the aortic endograft has two separate
nitinol ring stents separated from each other by a distance
of 8 to 11 mm. Four “pairs” of nitinol hooks protrude in
a caudal direction from the inferior ring described above
and provide a positive sealing function. The body itself
is unsupported by ring stents, which maximizes the avail-
able area through which fenestrations can be made. The
combination of the proximal sealing rings and the unsup-
ported body facilitates treatment of angulated necks.
One of the principal advantages of this stent graft system
is its repositionability; the “control collar” allows the
Fig 1. Angles measured in preoperative planning. All angles were
measured in relation to the long-axis of the aorta. A, Celiac trunk
angle. B, Renal artery angle. C, Infrarenal neck angle.D, Common
iliac artery angle. Superior mesenteric artery (SMA) angle measured
the same way as computed tomography (CT) angle.
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Volume 59, Number 3 Rolls et al 617interventionalist to collapse, rotate, advance, retract, and
ultimately redeploy the graft. The stent graft system allows
for cannulation of caudally angulated target vessels from
above, immediately following unsheathing of the stent
graft in a partially deployed state, but remains redeployable.
No other currently available device allows this.
Stent graft planning. CTA digital imaging and
communications in medicine data were imported into
a Phillips workstation (Phillips Healthcare) for 3D recon-
struction and for detailed assessment and measurement of
aneurysm morphology in order to facilitate graft planning.
Position, angulation, and size of target vessel ostia, aneu-
rysm neck length, diameter, and angulation, and position
of aortic bifurcation with respect to aneurysm sac as well
as iliac tortuosity were taken into account. All angulationmeasurements were taken in relation to the midline of
the aorta, as seen in Fig 1. Additionally, proximal landing
zone calciﬁcation and mural thrombus were taken into
account. In order to conﬁrm correct position of the
fenestrations with respect to ostia and to provide a pre-
procedure rehearsal opportunity for the primary operator,
prototype stents were developed and deployed in silicone
aortic models based on the each individual patient’s CTA
data.
Graft deployment. All procedures were performed in
the hybrid operating suite following induction of general
anesthesia. Bilateral common femoral arteries were exposed
surgically in all cases, and additional access was obtained
through the brachial arteries in order to facilitate target
vessel cannulation in cases where the latter were signiﬁ-
cantly caudally angulated. In some cases, where external
iliac arteries were found to be<7 mm in diameter, a Dacron
conduit was fashioned to facilitate passage of the delivery
system. A dosage of 100 IU/kg body-weight of unfrac-
tionated heparin was administered systemically immediately
prior to accessing the arterial system, and boluses were
administered throughout to keep the activated clotting
time at 250 to 300 seconds.
The main body was then positioned according to target
vessels; the position of the renals was used to determine the
craniocaudal position of the graft, and the “valleys” of the
proximal end of the main body were oriented anteroposter-
iorly in order to accommodate the superior mesenteric or
celiac arteries. In selected cases, fenestrations were used
to accommodate the SMA, and the “valley” was therefore
used to allow inﬂow into the celiac artery. Therefore
“peaks” are oriented laterally and above the renals in
most cases. Target vessels were then cannulated with
a combination of preshaped conventional catheters or
robotic (Hansen Medical, Mountain View, Calif) catheters.
After selective angiography to conﬁrm adequate target
vessel cannulation, V12 Advanta balloon-expandable
covered stents (Atrium Medical Corporation, Hudson,
NH) of suitable sizes were deployed through Ansel sheaths
(Cook Peripheral Intervention, Bloomington, Ind) and
ﬂared proximally. The iliac legs were subsequently
deployed with the aid of the magnetic cannulation system
for the contralateral limb and all junctions expanded with
a moulding balloon. Completion angiography was per-
formed to conﬁrm the absence of immediate complications
such as endoleak or target-vessel obstruction.
Follow-up and postoperative care. After completion
of the procedure, all patients were transferred to a specialist
vascular high-dependency unit, where invasive arterial and
central venous monitoring could be continued. The unit
has the capacity for systems support in the form of
noninvasive ventilation and inotrope/vasopressor circula-
tory support if required. Following discharge, all patients
were placed on a surveillance program consisting of CTA
and renal function testing at less than 1 month, 6 months,
and yearly thereafter. Speciﬁcally, reconstructions were
performed to identify branch stent stenoses.
Table II. Aneurysm morphology
Patient
No.
Sac size,
cm
Infrarenal neck
angulation
Coronal/AP, degrees
Aortic diameter
at renal level,
mm
Aortic diameter
at sealing zone,
mm
Degree of
thrombus
Degree of
calciﬁcation Neck length, mm
Operative
approacha
1 5.7 4/8 26 27 50% Minimal 5 Juxtarenal
2 6.4 49/64 22 26 45% Negative 9 Juxtarenal
3 8.8 24/65 26 23 Negative Negative 0 Juxtarenal
4 7.6 66/25 26 25 50% Negative 7.6 Juxtarenal
5 6.0 16/65 21 27 50% Negative 0 Type IV
6 5.9 47/20 24 26 Negative Negative 6.9 Juxtarenal
7 6.6 78/15 27 24 50% Negative 1 Juxtarenal
8 10.0 29/42 30 28 50% Negative Pre-exisiting stent Type IV
9 5.5 80/36 25 25 Negative Negative 5 Juxtarenal
10 9.0 73/53 23 27 Negative Negative Pre-existing stent Type IV
11 8.0 70/50 27 22 Negative Negative 2 Juxtarenal
12 7.7 32/23 29 26 Negative Negative Pre-existing stent Type IV
13 7.3 81/36 26 22 Negative Negative 7.1 Juxtarenal
aFor the purposes of this article, anatomical variants were classiﬁed by the operative approach that would have been required in open surgery: Juxtarenal, clamp
placed above renals; Type IV, medial visceral rotation with clamp placed above celiac axis.
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Demographics and indications. Over a period of
12 months, 13 fenestrated EVARs were performed on
patients who met appropriate indications for fenestrated
stenting and had two or more hostile anatomic features
using the Anaconda device. The cohort included ﬁve
females and eight males; median age was 75 years (range,
68-87 years). Patient American Society of Anesthesiologists
status ranged from III to IV, and comorbidities are listed in
Table I. Patient 1 demonstrated rapid growth (7 mm) in
the 6 months prior to intervention.
Aneurysm morphology. The mean aneurysmal sac
size was 7.3 cm (range, 5.5-10.0 cm). The mean infrarenal
neck length was 4.4 mm (range, 0-9 mm), and in three
cases was lined by a pre-existing stent and had type Ia
endoleaks (Table II). Nine cases had an infrarenal neck
angulation of at least 60

in either the AP or coronal planes;
three in the AP plane and six in the coronal plane. Mean
aortic diameter at the sealing zone was 25.1 mm (range,
22-27.7 mm) and at the level of the renal vessels 25.5 mm
(range, 22-30 mm). Five cases had 50% thrombosis at the
proximal landing zone. Three-dimensional reconstructions
of two of the cases are given as examples in Fig 2.
Target vessels. Thirty-ﬁve target vessels were cannu-
lated; two patients had one target vessel treated, three
had two vessels treated, ﬁve had three vessels treated, and
three had four vessels treated (Supplementary Table,
online only). The adverse anatomical features were six right
and six left renal artery ostial stenoses ($60%), six right and
four left renal arteries were angulated >120

, eight celiac
axes were likewise angulated >120

. One of the cannulated
SMAs was angulated >140

. Two-thirds of cannulated CTs
were angulated >120

, while one was stenotic.
Access vessels. Four right common iliac- and four left
common iliac arteries were angulated >90

. In three cases,
both common iliac arteries were angulated >90

. The
Supplementary Table (online only) gives common iliac arteryangulations encountered in each case. Only three patients
(1, 8, 12) did not have signiﬁcant neck or iliac tortuosity.
Technical success. The stent graft was successfully
deployed in all patients, and there were no technical issues
with the control or release mechanisms. Two patients
required repositioning of the main body before complete
deployment in order to align renal fenestrations with the
corresponding target vessels. In addition, this repositioning
feature was utilized to ‘restrain’ the stent graft from the
aortic wall, in order to aid cannulation of a fenestration
in the presence of a stenosed target vessel (Patient 3). A
total of 35 target vessels were cannulated successfully
through fenestrations, and there were no instances of
branch-stent occlusion or kinking on predischarge follow-
up scanning. One left renal artery was found to be
occluded on CT scan at 30 weeks. There was one instance
of a single iliac limb kink that did not result in signiﬁcant
hemodynamic or symptomatic consequences. Two endo-
leaks were identiﬁed on intraprocedural angiography: one
type III endoleak was identiﬁed arising from the junction
between the right renal stent and the corresponding
fenestration, and was managed intraoperatively by ﬂaring
the proximal portion of the stent with a 12 mm balloon. In
another patient, check angiography showed evidence of
a proximal type Ia endoleak: the anterior valley (accom-
modating the SMA) was held off the aorta by an irregu-
larity in the aortic wall, and stenting and ﬂaring the
SMA allowed apposition and seal, eliminating the type I
endoleak. Early CT scanning (median duration from
procedure, 4 days) demonstrated four type II endoleaks, as
seen in Table III. One early scan was delayed due to
contrast nephropathy and was subsequently performed at
the patient’s local hospital. Eleven patients had subsequent
CT scans (median duration to most recent scan, 33 weeks),
at which point one type II endoleak was observed. There
were no type I or type III endoleaks. There was concern
regarding graft infection in one patient who was
Fig 2. Three-dimensional reconstructions demonstrating adverse adverse anatomical features. a, Angulated neck,
narrowing of the aorta at the renal level, difﬁcult course of left renal artery, and angulated right common iliac artery. b,
Same patient post-treatment. c, Angulated neck, difﬁcult right renal artery take-off, caudally oriented left renal artery,
and tortuous iliacs bilaterally. d, Same patient post-treatment.
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therapy. Subsequently, all investigations have proven
negative for an infected graft, and the patient is now off
antibiotics and remains well. Two patients demonstrated
aneurysm growth following the procedure, although no
endoleak was demonstrated, and both were closely
observed. One of these patients (Patient 2) underwent
ultraselective angiography of his lumbar arteries, which
failed to demonstrate endoleak despite a growing sac size;
this patient is awaiting further urgent imaging with MRI
followed by multidisciplinary discussion.
Morbidity and mortality. Mortality at 30 days was
0%. Mean estimated blood loss was 650 mL (range, 400-
1000 mL). Mean length of stay was 8.5 days (range,
4-20 days), and there was no signiﬁcant difference between
preprocedure and predischarge creatinine (P ¼ .24; Wil-
coxon signed rank test). One patient experienced a trans-
ected left brachial artery, requiring repair with a vein
graft in the same operative session. Prolonged left leg
ischemia resulted in compartment syndrome and fasciot-
omy, and subsequent acute renal failure required a 7-day
intensive care unit stay for hemoﬁltration. Shortly prior
to discharge to a rehabilitation unit, blood culture revealed
Gram-negative rods, requiring placement of a peripherallyinserted central catheter and a 6-week course of ertapenem.
This patient’s renal function returned to baseline. One
patient had asymptomatic infarction of the tip of inferior
pole of the right kidney as a result of coverage of an
accessory right renal vessel by a renal stent that was
deployed in the dominant vessel. Renal function in this
patient deteriorated transiently but then returned to base-
line levels. No patients remained dialysis-dependent.
DISCUSSION
This article describes the use of the Anaconda fenes-
trated stent graft in complicated anatomical scenarios and
is, to our knowledge, the largest series documenting its
use. This patient cohort included patients with juxta- and
pararenal, as well as type IV thoracoabdominal morpholog-
ical conﬁgurations, and all these patients had two or more
anatomical features that were considered unfavorable. The
most widely recognized fenestrated device is the Cook
Zenith (Cook Medical), with which we have signiﬁcant
experience.9 For patients either unsuitable for the Cook
graft or where we felt signiﬁcant advantage could be gained
in particularly challenging anatomical conﬁgurations, we
used the Anaconda fenestrated device. These advantages
included the ability to cannulate from a brachial approach
Table III. Short-term outcomes
Patient No.
Estimated blood
loss, mL
Length of
stay, days
Discharge
disposition
Preop
creatinine, mmol/L
Predischarge
creatinine, mmol/L Time to initial scan, days
1 750 12 Rehab Unit 145 186 8
2 400 6 Home 80 136 252 (delayed eimpaired
renal function)
3 550 5 Home 83 71 3
4 550 9 Home 169 228 5
5 500 20 Home 109 277 2
6 450 8 Home 78 91 1
7 800 9 Home 101 95 7
8 1000 5 Home 64 55 5
9 500 8 Home 55 56 3
10 650 5 Home 79 88 2
11 800 8 Home 72 56 7
12 1000 4 Home 81 73 3
13 500 11 Home 62 50 4
LRA, left renal artery.
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signiﬁcant iliac tortuosity, and/or severe infrarenal neck
angulation (10 patients), all of which may hinder cannula-
tion attempts. The unsupported main body places fewer
restrictions in terms of the fenestration site, which in this
series facilitated cannulation of two renal targets that
were very close to each other. Additionally, the graft was
repositionable in two cases where aligning renal fenestra-
tions with target vessels was complicated by neck angula-
tion. This early series seems to be successful in terms of
aneurysm exclusion; there were no type I or III endoleaks
despite signiﬁcant neck angulation in nine patients.
The use of the Anaconda fenestrated stent graft system
has been described in a series describing its application and
immediate as well as short-term outcomes (1 month) in
four patients with short-neck infrarenal and juxtarenal
aneurysms.2 In the present series, the longest period of
follow-up was 65 weeks. The largest two series of fenes-
trated stent grafting to date describe the use of the Cook
fenestrated stent graft, with a maximum of 8 and 4.4 years
of follow-up, respectively.12,13 Although a direct compar-
ison of this data with the present series is therefore not
ideal, in both of these series, predischarge endoleaks were
a composite of types I, II, and III. Two endoleaks were
identiﬁed in this series on intraprocedural angiography
that required adjunctive measures to obtain a better seal.
Four type II endoleaks were noted on discharge, and one
type II endoleak at the date of most recent CTA (median,
33 weeks). We identiﬁed a single left renal artery occlusion
on CTA at 30 weeks that was not present at predischarge
scanning. We fully appreciate that these results are difﬁcult
to interpret and put into context of existing literature
owing to small numbers and short follow-up period.
Reports vary in terms of when the majority of occlusions
occur, ranging from mainly within the ﬁrst year and up
to 36 months in the French multicenter experience.13,14
All occlusions in their single-center experience occurred
within the ﬁrst year.14 In the present series, none of the13 stenosed vessels required reintervention following the
initial bridging stent.
The emphasis of this work is on the utility of a novel
fenestrated stent graft system in overcoming challenging
anatomical scenarios. Planning of successful fenestrated
endovascular intervention needs to bear in mind multiple
anatomical factors including aortic morphology, target
vessel angulation and diameter, and access vessel tortuosity.
Rodd et al describe an anatomical scoring system for thor-
acoabdominal aortic aneurysms in order to determine suit-
ability for repair by pure endovascular means.10 Some
components of this assessment tool can be applied to the
anatomical scenarios described in this study, including
target vessel angulation and stenosis and length of proximal
and distal landing zones. However, the authors emphasize
angulation of the arch itself and the junction between the
aortic arch and descending thoracic aorta. Of interest in
this study were advantages that a repositionable stent graft
system with an unsupported main body might confer
during cannulation of challenging targets, which were on
occasion positioned on or adjacent to an angulated infrare-
nal neck. The added advantage of this system is the ability
to cannulate the target vessel antegradely while the system
is still partially deployed and adjustable. Numerous studies
have correlated anatomical complexity in this regard with
clinical outcome in standard EVAR in IRAAA; severe
neck angulation has been deﬁned previously as angle
$60

of the long axis of the aneurysm sac in relation to
the abdominal aorta and has been identiﬁed as an indepen-
dent prognostic indicator of adverse outcomes.15-18
A combination of main body ﬂexibility and high prox-
imal ﬁxation strength in theory provides a means of over-
coming this anatomical problem, and manufacturers have
focused on the development of such devices. The standard
nonfenestrated Anaconda graft, in addition to the ﬂexibility
of its main body, has demonstrated superior proximal ﬁxa-
tion strength as opposed other grafts and has delivered
promising results in initial studies.19-21 We identiﬁed two
Radiological ﬁndings
at initial scan Time to most recent scan, weeks Preop sac size, cm
Sac size at ﬁnal
scan, cm Radiological ﬁndings at ﬁnal scan
No endoleak Emigrated prior to follow-up 5.7 5.5 -
8.7 cm sac 61 6.4 9.1 Increasing sac size, no endoleak
Type II endoleak Died ischemic heart disease 77weeks 8.8 9.0 -
Type II endoleak 30 7.6 7.3 No endoleak, occluded LRA
No endoleak 42 6.0 5.8 No endoleak
No endoleak 69 5.9 5.1 No endoleak
Type II endoleak 65 6.6 4.9 No endoleak
No endoleak 37 10 10 Type II endoleak
No endoleak 33 5.5 4.7 No endoleak
No endoleak 25 9.0 8.9 No endoleak
No endoleak 32 8.0 7.4 No endoleak
Type II endoleak 39 7.7 8.3 Increasing sac size, no endoleak
No endoleak 48 7.3 7.0 No endoleak
Table III. Continued.
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peratively. We did not observe any delayed type I or III
endoleaks despite severe neck angulation in 69% of cases,
although we acknowledge limited follow-up times in
some cases of this series.
There is a paucity of data relating to endoleak rates in
FEVAR. EUROSTAR (European Collaborators on Stent-
Graft Techniques for Abdominal Aortic Aneurysm Repair
Registry) data suggest that standard infrarenal EVAR
patients with necks <15 mm in length experienced signif-
icantly higher rates of type I endoleaks within 30 days.22
In theory, this risk is obviated by the ability to land the
fenestrated graft on a suprarenal landing zone. Three
patients in this series who had previously developed delayed
type Ia endoleaks following EVAR underwent relining of
the proximal portion of a pre-existing stent graft using
fenestrated Anaconda cuff extensions. Vourliotakis et al
describe a positive experience with Cook fenestrated grafts
for the management of juxta- and pararenal aneurysmal
degeneration following previous EVAR in a series of nine
patients.23 To our knowledge, the data presented in this
study are the ﬁrst to describe the use of the Anaconda graft
in this particular setting. The redeployable nature of the
graft and the unsupported main body facilitated cannula-
tion of the target vessels, and we did not encounter addi-
tional difﬁculties as a result of the pre-existing stents.CONCLUSIONS
The deployment of the fenestrated Anaconda stent
graft system was technically feasible in cases with anatom-
ical complexity. This was facilitated by the unsupported
and repositionable main body, as well as antegrade cannu-
lation of target vessels early on in the procedure when the
system is still under the operator’s control. Short-term
results are encouraging in terms of endoleak, target vessel,
and iliac limb patency rates. Longer follow-up is warranted
to identify durability of this system in terms of late compli-
cations such as graft migration and component separation.AUTHOR CONTRIBUTIONS
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Supplementary Table (online only). Target/access vessels
Patient
Vessels
fenestrated
RRA
diameter,
mm
RRA
angulation,
degrees
LRA
diameter,
mm
LRA
angulation,
degrees
SMA
diameter,
mm
SMA
angulation,
degrees
CT
diameter,
mm
CT
angulation,
degrees
LCIA
angulation,
degrees
RCIA
(angulation,
degrees)
1 2 (LRA, RRA) 4 (S) - 4.5 (S) 150 - - - - - -
2 2 (LRA, RRA) - 129 - - - - - - - -
3 1 (RRA) - 128 - 134 - - - - - -
4 4 (LRA, RRA, SMA, CT) - 123 - - - - 7.9 (S) 125 - -
5 3 (LRA, RRA, SMA) 5 (S) 137 5 (S) - - - - - 95 -
6 1 (RRA) - 127 - - - - - - 98 93
7 2 (LRA, RRA) 5.8 (S) - 5 (S) - - - - - - 90
8 4 (LRA, RRA, SMA, CT) 6.8 (S) - 6 (S) - - - - 130 - -
9 3 (LRA, RRA, SMA) - - - 140 - - - - - -
10 3 (LRA, RRA, SMA) 4.5 (S) 129 - - - - - - - -
11 3 (LRA, RRA, SMA) - - 5 (S) 150 - 149 - - 108 103
12 4 (LRA, RRA, SMA, CT) 5 (S) - 5.5 (S) - - - - - - -
13 3 (2x RRA, LRA) - - - - - - - - 105 98
CT, Celiac trunk; LCIA, left common iliac artery; LRA, left renal artery; RCIA, right common iliac artery; RRA, right renal artery; SMA, superior mesenteric
artery.
Values are given only for those target vessels that were classiﬁed as anatomically challenging.
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